Robert F. Kennedy Jr. (RFK Jr.), the newly appointed U.S. Secretary of Health and Human Services, has made controversial statements about antidepressants. During his confirmation hearing, he raised concerns about the effects of SSRIs, drawing both support and criticism. His remarks have sparked debate among lawmakers and health experts, with some questioning their accuracy and potential impact.
Here are…
